Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lasmiditan long-term safety in migraine (GLADIATOR)
NCT02565186Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of lasmiditan in migraine, sponsored by Eli Lilly and Company. Started Oct 2015; status: completed.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02565186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565186.